Biology of the blood-brain barrier: Part I;Biologie de la barrière hématoencéphalique : Partie I

Revue Neurologique

Volumn 165, Issue 11, 2009, Pages 863-874

  Weiss, N ^a,b,c   Miller, F ^a,b   Cazaubon, S ^a,b   Couraud, P O ^a,b  

^a INSTITUT COCHIN   (France)

^b INSERM   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Blood brain barrier; Cellular migration; Cerebral endothelium; Transporters

Indexed keywords

ABC TRANSPORTER; BREAST CANCER RESISTANCE PROTEIN; GLYCOPROTEIN P; XENOBIOTIC AGENT;

ASTROCYTE; BLOOD BRAIN BARRIER; BRAIN BLOOD VESSEL; BRAIN CELL; CELL JUNCTION; CELL MEMBRANE PERMEABILITY; CELL MIGRATION; HUMAN; INTRACELLULAR SPACE; NERVE CELL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVIEW;

ASTROCYTES; BIOLOGICAL TRANSPORT; BLOOD-BRAIN BARRIER; CAPILLARIES; CELL MEMBRANE PERMEABILITY; CENTRAL NERVOUS SYSTEM; CEREBROVASCULAR CIRCULATION; ENDOTHELIUM, VASCULAR; ENERGY METABOLISM; HUMANS; NEURONS; XENOBIOTICS;

EID: 70350710063     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurol.2009.03.004     Document Type: Review

References (94)

1. Abbott N.J., Ronnback L., and Hansson E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 7 (2006) 41-53
2. Abrahamson D.R. Recent studies on the structure and pathology of basement membranes. J Pathol 149 (1986) 257-278
3. Amiry-Moghaddam M., and Ottersen O.P. The molecular basis of water transport in the brain. Nat Rev Neurosci 4 (2003) 991-1001
4. Balda M.S., Whitney J.A., Flores C., Gonzalez S., Cereijido M., and Matter K. Functional dissociation of paracellular permeability and transepithelial electrical resistance and disruption of the apical-basolateral intramembrane diffusion barrier by expression of a mutant tight junction membrane protein. J Cell Biol 134 (1996) 1031-1049
5. Ballabh P., Braun A., and Nedergaard M. The blood-brain barrier: an overview: structure, regulation, and clinical implications. Neurobiol Dis 16 (2004) 1-13
6. Barreiro O., Yanez-Mo M., Serrador J.M., Montoya M.C., Vicente-Manzanares M., Tejedor R., et al. Dynamic interaction of VCAM-1 and ICAM-1 with moesin and ezrin in a novel endothelial docking structure for adherent leukocytes. J Cell Biol 157 (2002) 1233-1245
7. Begley D.J. ABC transporters and the blood-brain barrier. Curr Pharm Des 10 (2004) 1295-1312
8. Berzin T.M., Zipser B.D., Rafii M.S., Kuo-Leblanc V., Yancopoulos G.D., Glass D.J., et al. Agrin and microvascular damage in Alzheimer's disease. Neurobiol Aging 21 (2000) 349-355
9. Brightman M.W., and Kadota Y. Nonpermeable and permeable vessels of the brain. NIDA Res Monogr 120 (1992) 87-107
10. Carman C.V., Jun C.D., Salas A., and Springer T.A. Endothelial cells proactively form microvilli-like membrane projections upon intercellular adhesion molecule 1 engagement of leukocyte LFA-1. J Immunol 171 (2003) 6135-6144
11. Carman C.V., Sage P.T., Sciuto T.E., de la Fuente M.A., Geha R.S., Ochs H.D., et al. Transcellular diapedesis is initiated by invasive podosomes. Immunity 26 (2007) 784-797
12. Carman C.V., and Springer T.A. Trans-cellular migration: cell-cell contacts get intimate. Curr Opin Cell Biol 20 (2008) 533-540
13. Chan A.K., Goedegebuure P.S., von Bernstorff W., Carritte A.L., Chung M., Stewart R.A., et al. B7, 1 costimulation increases T-cell proliferation and cytotoxicity via selective expansion of specific variable alpha and beta genes of the T-cell receptor. Surgery 127 (2000) 342-350
14. Chavakis T., Preissner K.T., and Santoso S. Leukocyte trans-endothelial migration: JAMs add new pieces to the puzzle. Thromb Haemost 89 (2003) 13-17
15. Chen X., Walker D.G., Schmidt A.M., Arancio O., Lue L.F., and Yan S.D. RAGE: a potential target for Abeta-mediated cellular perturbation in Alzheimer's disease. Curr Mol Med 7 (2007) 735-742
16. Chen Y., Merzdorf C., and Goodenough D.A. COOH terminus of occludin is required for tight junction barrier function in early Xenopus embryos. J Cell Biol 138 (1997) 891-899
17. Cisternino S., Rousselle C., Debray M., and Scherrmann J.M. In situ transport of vinblastine and selected P-glycoprotein substrates: implications for drug-drug interactions at the mouse blood-brain barrier. Pharm Res 21 (2004) 1382-1389
18. Cordon-Cardo C., O'Brien J.P., Casals D., Rittman-Grauer L., Biedler J.L., Melamed M.R., et al. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc Natl Acad Sci U S A 86 (1989) 695-698
19. Dauchy S., Dutheil F., Weaver R.J., Chassoux F., Daumas-Duport C., Couraud P.O., et al. ABC transporters, cytochromes P450 and their main transcription factors: expression at the human blood-brain barrier. J Neurochem 107 (2008) 1518-1528
20. de Boer A.G., van der Sandt I.C., and Gaillard P.J. The role of drug transporters at the blood-brain barrier. Annu Rev Pharmacol Toxicol 43 (2003) 629-656
21. de Lange E.C. Potential role of ABC transporters as a detoxification system at the blood-CSF barrier. Adv Drug Deliv Rev 56 (2004) 1793-1809
22. Deane R., Wu Z., and Zlokovic B.V. RAGE (yin) versus LRP (yang) balance regulates alzheimer amyloid beta-peptide clearance through transport across the blood-brain barrier. Stroke 35 Suppl. 1 (2004) 2628-2631
23. Deeley R.G., and Cole S.P. Substrate recognition and transport by multidrug resistance protein 1 (ABCC1). FEBS Lett 580 (2006) 1103-1111
24. Dehouck B., Fenart L., Dehouck M.P., Pierce A., Torpier G., and Cecchelli R. A new function for the LDL receptor: transcytosis of LDL across the blood-brain barrier. J Cell Biol 138 (1997) 877-889
25. Dejana E. The transcellular railway: insights into leukocyte diapedesis. Nat Cell Biol 8 (2006) 105-107
26. Descamps L., Dehouck M.P., Torpier G., and Cecchelli R. Receptor-mediated transcytosis of transferrin through blood-brain barrier endothelial cells. Am J Physiol 270 (1996) H1149-H1158
27. Dolman D., Drndarski S., Abbott N.J., and Rattray M. Induction of aquaporin 1 but not aquaporin 4 messenger RNA in rat primary brain microvessel endothelial cells in culture. J Neurochem 93 (2005) 825-833
28. Dombrowski S.M., Desai S.Y., Marroni M., Cucullo L., Goodrich K., Bingaman W., et al. Overexpression of multiple drug resistance genes in endothelial cells from patients with refractory epilepsy. Epilepsia 42 (2001) 1501-1506
29. Duffy K.R., and Pardridge W.M. Blood-brain barrier transcytosis of insulin in developing rabbits. Brain Res 420 (1987) 32-38
30. Dziegielewska K.M., Ek J., Habgood M.D., and Saunders N.R. Development of the choroid plexus. Microsc Res Tech 52 (2001) 5-20
31. Engelhardt B., and Ransohoff R.M. The ins and outs of T-lymphocyte trafficking to the CNS: anatomical sites and molecular mechanisms. Trends Immunol 26 (2005) 485-495
32. Engelhardt B., Vestweber D., Hallmann R., and Schulz M. E- and P-selectin are not involved in the recruitment of inflammatory cells across the blood-brain barrier in experimental autoimmune encephalomyelitis. Blood 90 (1997) 4459-4472
33. Engelhardt B., and Wolburg H. Mini-review: Transendothelial migration of leukocytes: through the front door or around the side of the house?. Eur J Immunol 34 (2004) 2955-2963
34. Fishman B.E., McGinley P.A., and Gianutsos G. Neurotoxic effects of methylcyclopentadienyl manganese tricarbonyl (MMT) in the mouse: basis of MMT-induced seizure activity. Toxicology 45 (1987) 193-201
35. Furuse M., Fujita K., Hiiragi T., Fujimoto K., and Tsukita S. Claudin-1 and -2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin. J Cell Biol 141 (1998) 1539-1550
36. Furuse M., Furuse K., Sasaki H., and Tsukita S. Conversion of zonulae occludentes from tight to leaky strand type by introducing claudin-2 into Madin-Darby canine kidney I cells. J Cell Biol 153 (2001) 263-272
37. Furuse M., Sasaki H., and Tsukita S. Manner of interaction of heterogeneous claudin species within and between tight junction strands. J Cell Biol 147 (1999) 891-903
38. Gaillard P.J., Visser C.C., and de Boer A. Targeted delivery across the blood-brain barrier. Expert Opin Drug Deliv 2 (2005) 299-309
39. Hauw J.J., and Lefauconnier J.M. [The blood-brain barrier. I. Morphologic data]. Rev Neurol (Paris) 139 (1983) 611-624
40. Hori S., Ohtsuki S., Hosoya K., Nakashima E., and Terasaki T. A pericyte-derived angiopoietin-1 multimeric complex induces occludin gene expression in brain capillary endothelial cells through Tie-2 activation in vitro. J Neurochem 89 (2004) 503-513
41. Itoh M., Furuse M., Morita K., Kubota K., Saitou M., and Tsukita S. Direct binding of three tight junction-associated MAGUKs, ZO-1, ZO-2, and ZO-3, with the COOH termini of claudins. J Cell Biol 147 (1999) 1351-1363
42. Janzer R.C., and Raff M.C. Astrocytes induce blood-brain barrier properties in endothelial cells. Nature 325 (1987) 253-257
43. Jefferies W.A., Brandon M.R., Hunt S.V., Williams A.F., Gatter K.C., and Mason D.Y. Transferrin receptor on endothelium of brain capillaries. Nature 312 (1984) 162-163
44. Johnson-Leger C., Aurrand-Lions M., and Imhof B.A. The parting of the endothelium: miracle, or simply a junctional affair?. J Cell Sci 113 (2000) 921-933
45. Juliano R.L., and Ling V. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta 455 (1976) 152-162
46. Kusuhara H., and Sugiyama Y. Active efflux across the blood-brain barrier: role of the solute carrier family. NeuroRx 2 (2005) 73-85
47. Lee S.W., Kim W.J., Choi Y.K., Song H.S., Son M.J., Gelman I.H., et al. SSeCKS regulates angiogenesis and tight junction formation in blood-brain barrier. Nat Med 9 (2003) 900-906
48. Lennon V.A., Kryzer T.J., Pittock S.J., Verkman A.S., and Hinson S.R. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 202 (2005) 473-477
49. Liebner S., Fischmann A., Rascher G., Duffner F., Grote E.H., Kalbacher H., et al. Claudin-1 and claudin-5 expression and tight junction morphology are altered in blood vessels of human glioblastoma multiforme. Acta Neuropathol 100 (2000) 323-331
50. Lindahl P., Johansson B.R., Leveen P., and Betsholtz C. Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science 277 (1997) 242-245
51. Loscher W., and Potschka H. Blood-brain barrier active efflux transporters: ATP-binding cassette gene family. NeuroRx 2 (2005) 86-98
52. Loscher W., and Potschka H. Drug resistance in brain diseases and the role of drug efflux transporters. Nat Rev Neurosci 6 (2005) 591-602
53. McKinley M.J., McAllen R.M., Davern P., Giles M.E., Penschow J., Sunn N., et al. The sensory circumventricular organs of the mammalian brain. Adv Anat Embryol Cell Biol 172 (2003) 1-122 back cover
54. Millan J., Hewlett L., Glyn M., Toomre D., Clark P., and Ridley A.J. Lymphocyte transcellular migration occurs through recruitment of endothelial ICAM-1 to caveola- and F-actin-rich domains. Nat Cell Biol 8 (2006) 113-123
55. Miller F., Fenart L., Landry V., Coisne C., Cecchelli R., Dehouck M.P., et al. The MAP kinase pathway mediates transcytosis induced by TNF-alpha in an in vitro blood-brain barrier model. Eur J Neurosci 22 (2005) 835-844
56. Morita K., Sasaki H., Furuse M., and Tsukita S. Endothelial claudin: claudin-5/TMVCF constitutes tight junction strands in endothelial cells. J Cell Biol 147 (1999) 185-194
57. Murakami N., Sakata Y., and Watanabe T. Central action sites of interleukin-1 beta for inducing fever in rabbits. J Physiol 428 (1990) 299-312
58. Nandi A., Estess P., and Siegelman M. Bimolecular complex between rolling and firm adhesion receptors required for cell arrest; CD44 association with VLA-4 in T cell extravasation. Immunity 20 (2004) 455-465
59. Nies A., Jedlitschky G., Konig J., Herold-Mende C., Steiner H.H., Schmitt H.P., et al. Expression and immunolocalization of the multidrug resistance proteins, MRP1-MRP6 (ABCC1-ABCC6), in human brain. Neuroscience 129 (2004) 349-360
60. Nitta T., Hata M., Gotoh S., Seo Y., Sasaki H., Hashimoto N., et al. Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J Cell Biol 161 (2003) 653-660
61. Nutt J.G., Woodward W.R., Hammerstad J.P., Carter J.H., and Anderson J.L. The "on-off" phenomenon in Parkinson's disease. Relation to levodopa absorption and transport. N Engl J Med 310 (1984) 483-488
62. Ohtsuki S., and Terasaki T. Contribution of carrier-mediated transport systems to the blood-brain barrier as a supporting and protecting interface for the brain; importance for CNS drug discovery and development. Pharm Res 24 (2007) 1745-1758
63. Ostermann G., Weber K.S., Zernecke A., Schroder A., and Weber C. JAM-1 is a ligand of the beta(2) integrin LFA-1 involved in transendothelial migration of leukocytes. Nat Immunol 3 (2002) 151-158
64. Pardridge W. Introduction to the blood-brain barrier: methodology, biology and pathology (1998), Cambridge University Press, Cambridge, United Kingdom
65. Pardridge W.M. Blood-brain barrier delivery. Drug Discov Today 12 (2007) 54-61
66. Pardridge W.M., Boado R.J., and Kang Y.S. Vector-mediated delivery of a polyamide ("peptide") nucleic acid analogue through the blood-brain barrier in vivo. Proc Natl Acad Sci U S A 92 (1995) 5592-5596
67. Peppiatt C.M., Howarth C., Mobbs P., and Attwell D. Bidirectional control of CNS capillary diameter by pericytes. Nature 443 (2006) 700-704
68. Perlmutter L.S., and Chui H.C. Microangiopathy, the vascular basement membrane and Alzheimer's disease: a review. Brain Res Bull 24 (1990) 677-686
69. Persidsky Y., Ramirez S.H., Haorah J., and Kanmogne G.D. Blood-brain barrier: structural components and function under physiologic and pathologic conditions. J Neuroimmune Pharmacol 1 (2006) 223-236
70. Petty M.A., and Lo E.H. Junctional complexes of the blood-brain barrier: permeability changes in neuroinflammation. Prog Neurobiol 68 (2002) 311-323
71. Roberts L.M., Black D.S., Raman C., Woodford K., Zhou M., Haggerty J.E., et al. Subcellular localization of transporters along the rat blood-brain barrier and blood-cerebral-spinal fluid barrier by in vivo biotinylation. Neuroscience 155 (2008) 423-438
72. Saadoun S., Papadopoulos M.C., Watanabe H., Yan D., Manley G.T., and Verkman A.S. Involvement of aquaporin-4 in astroglial cell migration and glial scar formation. J Cell Sci 118 (2005) 5691-5698
73. Schinkel A.H., Mayer U., Wagenaar E., Mol C.A., van Deemter L., Smit J.J., et al. Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins. Proc Natl Acad Sci U S A 94 (1997) 4028-4033
74. Schinkel A.H., Smit J.J., van Tellingen O., Beijnen J.H., Wagenaar E., van Deemter L., et al. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 77 (1994) 491-502
75. Sellebjerg F., and Sorensen T.L. Chemokines and matrix metalloproteinase-9 in leukocyte recruitment to the central nervous system. Brain Res Bull 61 (2003) 347-355
76. Steeber D.A., Venturi G.M., and Tedder T.F. A new twist to the leukocyte adhesion cascade: intimate cooperation is key. Trends Immunol 26 (2005) 9-12
77. Tait M.J., Saadoun S., Bell B.A., and Papadopoulos M.C. Water movements in the brain: role of aquaporins. Trends Neurosci 31 (2008) 37-43
78. Thiebaut F., Tsuruo T., Hamada H., Gottesman M.M., Pastan I., and Willingham M.C. Immunohistochemical localization in normal tissues of different epitopes in the multidrug transport protein P170: evidence for localization in brain capillaries and crossreactivity of one antibody with a muscle protein. J Histochem Cytochem 37 (1989) 159-164
79. Tsuji A. Small molecular drug transfer across the blood-brain barrier via carrier-mediated transport systems. NeuroRx 2 (2005) 54-62
80. Tsukita S., and Furuse M. Occludin and claudins in tight-junction strands: leading or supporting players?. Trends Cell Biol 9 (1999) 268-273
81. Ullrich S.E. Suppression of lymphoproliferation by hapten-specific suppressor T lymphocytes from mice exposed to ultraviolet radiation. Immunology 54 (1985) 343-352
82. van Buul J.D., and Hordijk P.L. Signaling in leukocyte transendothelial migration. Arterioscler Thromb Vasc Biol 24 (2004) 824-833
83. Van Lint P., and Libert C. Chemokine and cytokine processing by matrix metalloproteinases and its effect on leukocyte migration and inflammation. J Leukoc Biol 82 (2007) 1375-1381
84. Vannucci S.J., Maher F., and Simpson I.A. Glucose transporter proteins in brain: delivery of glucose to neurons and glia. Glia 21 (1997) 2-21
85. Viegas P., Chaverot N., Enslen H., Perriere N., Couraud P.O., and Cazaubon S. Junctional expression of the prion protein PrPC by brain endothelial cells: a role in trans-endothelial migration of human monocytes. J Cell Sci 119 (2006) 4634-4643
86. Visser C.C., Stevanovic S., Heleen Voorwinden L., Gaillard P.J., Crommelin D.J., Danhof M., et al. Validation of the transferrin receptor for drug targeting to brain capillary endothelial cells in vitro. J Drug Target 12 (2004) 145-150
87. Weber C., Fraemohs L., and Dejana E. The role of junctional adhesion molecules in vascular inflammation. Nat Rev Immunol 7 (2007) 467-477
88. Wolburg H., and Lippoldt A. Tight junctions of the blood-brain barrier: development, composition and regulation. Vascul Pharmacol 38 (2002) 323-337
89. Wolburg H., Wolburg-Buchholz K., and Engelhardt B. Diapedesis of mononuclear cells across cerebral venules during experimental autoimmune encephalomyelitis leaves tight junctions intact. Acta Neuropathol 109 (2005) 181-190
90. Wong A.S., and Gumbiner B.M. Adhesion-independent mechanism for suppression of tumor cell invasion by E-cadherin. J Cell Biol 161 (2003) 1191-1203
91. Wosik K., Cayrol R., Dodelet-Devillers A., Berthelet F., Bernard M., Moumdjian R., et al. Angiotensin II controls occludin function and is required for blood brain barrier maintenance: relevance to multiple sclerosis. J Neurosci 27 (2007) 9032-9042
92. Yong V.W. Metalloproteinases: mediators of pathology and regeneration in the CNS. Nat Rev Neurosci 6 (2005) 931-944
93. Zhang B., Dhillon S., Geary I., Howell W.M., Iannotti F., Day I.N., et al. Polymorphisms in matrix metalloproteinase-1, -3, -9, and -12 genes in relation to subarachnoid hemorrhage. Stroke 32 (2001) 2198-2202
94. Zhang Y., and Pardridge W.M. Rapid transferrin efflux from brain to blood across the blood-brain barrier. J Neurochem 76 (2001) 1597-1600